In this retrospective observational study, we have analyzed HMGB-1, OPG and inflammatory cytokines serum levels in 1393 type 2 diabetic patients with PAD and without PAD (WPAD). This evidence concerns the gene TNFRSF11B and type 2 diabetes mellitus.